Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Apotex Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (1354)
Cancellation or suspension (47)
Prescription medicine registration (18)
ARTG (8)
Australian Public Assessment Report (AusPAR) (1)
Listed medicine compliance report (1)
Prescription medicine decision summary (1)
Section 14, TGO91 consent (1)

Date

2024 (4)
2023 (16)
2022 (159)
2021 (104)
2020 (216)
2019 (124)
2018 (380)
2017 (307)
2016 (37)
2015 (52)
2014 (32)

Results for "[search-keyword]"

Search

Sponsor content

1431 result(s) found, displaying 481 to 490

APO-TADALAFIL tadalafil 20mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

13 March 2020

Cancellation by sponsor

Requested by Apotex Pty Ltd
BLOOMS THE CHEMIST ROSUVASTATIN 20 mg rosuvastatin calcium 20 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

13 March 2020

Cancellation by sponsor

Requested by Apotex Pty Ltd
BLOOMS THE CHEMIST ROSUVASTATIN 10 mg rosuvastatin calcium 10 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

13 March 2020

Cancellation by sponsor

Requested by Apotex Pty Ltd
BLOOMS THE CHEMIST CELECOXIB Celecoxib 100 mg capsule blister pack Cancelled under Section 30(1)(c) of the Act

13 March 2020

Cancellation by sponsor

Requested by Apotex Pty Ltd
BLOOMS THE CHEMIST CELECOXIB Celecoxib 200 mg capsule blister pack Cancelled under Section 30(1)(c) of the Act

13 March 2020

Cancellation by sponsor

Requested by Apotex Pty Ltd
Oviit Krill Oil 1000mg Cancelled under Section 30(1)(c) of the Act

4 March 2020

Cancellation by sponsor

Requested by Apotex Pty Ltd
Enoxapo

28 February 2020

Prescription medicine decision summary

Australian prescription medicine decision summary
Oviit Krill Oil 1000mg (Apotex Pty Ltd)

20 February 2020

Listed medicine compliance report

Medicine continues to be permitted for supply (View full entry for advice on the safety of using this medicine.)
APO-PACLITAXEL, PACLITAXEL APOTEX (Apotex Pty Ltd)

6 February 2020

Prescription medicine registration

Active ingredients: paclitaxel.
ENOXAPO (Apotex Pty Ltd)

4 February 2020

Prescription medicine registration

Active ingredients: enoxaparin sodium.

Pages

First page
Previous page
…
Page 45
Page 46
Page 47
Page 48
Current page 49
Page 50
Page 51
Page 52
Page 53
…
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.